Clinical Trials by Tumor Biology & Microbiology Program Members

Dr. Vaishampayan is conducting a pilot trial of oral cabozantinib/ XL184 in metastatic castrate resistant prostate cancer to explore the changes in bone and tumor imaging related pathways (KCI Protocol # 2011-185). It is now closed to accrual, but research related intervention and follow up are ongoing.

In collaboration with Dr. Gadgeel (MT), Dr. Hillman studies the effects of soy isoflavones on decreasing or preventing the inflammation associated with lung cancer radiation therapy (Hillman G, J Thorac Oncol, 2013). Based on this study, there is a PI-initiated clinical trial of Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients with Stage IIIA-IIIB Non-Small Cell Lung Cancer (KCI protocol #2013-021).

Drs. Vaishampayan and Heath (MT) are co-investigators on a multi-institutional study to evaluate immune responses to Sipuleucel-T in African American men and non-African American men with castrate resistant prostate cancer (Protocol #2013-108) which is a multi-center grant involving the Prostate Cancer Clinical Trials consortium [(Barbara Ann Karmanos Cancer Center (Wayne State University), Carbone Cancer Center (University of Wisconsin), Dana-Farber Cancer Institute (Harvard Medical School), Duke Cancer Institute, Fred Hutchinson Cancer Research Center (University of Washington), Helen Diller Family Comprehensive Cancer Center (University of California San Francisco), Knight Cancer Institute (Oregon Health and Science University), MD Anderson Cancer Center (University of Texas), Memorial Sloan Kettering Cancer Center, Sidney Kimmel Comprehensive Cancer Center (Johns Hopkins University), University of Chicago Comprehensive Cancer Center, University of Medicine and Dentistry of New Jersey, and Henry Ford Health System. 

More Information

For more information on these trials, or to view all clinical trials available at Karmanos Cancer Institute, please click here

The Latest From Karmanos Cancer Institute

News

KSP, McLaren’s Specialty Pharmacy, Recognized as a Leader in Performance Measurement for Third Consecutive Year

The Utilization Review Accreditation Commission (URAC) has again awarded KSP , McLaren’s Specialty Pharmacy, as a 2024 Specialty Pharmacy Pioneer ...

Read More

Tickets on Sale Now, Karmanos Cancer Institute’s 3rd Annual Classic Cars for the Cure

The  Barbara Ann Karmanos Cancer Institute is gearing up for the third annual Classic Cars for the Cure on Saturday, Sept. 20. Tickets are no...

Read More

Is It Time to Schedule Your Cancer Screenings? Here’s What You Need to Know

If you’re at the age where cancer screenings are recommended—or even overdue—consider this your reminder to get them on the calendar. Just like yo...

Read More
News

105.9 KISS FM | Getting a Second Opinion at Karmanos

Listen Now

WJR | Karmanos Cancer Institute Continues Its Community Education Series

Listen Now

WXYT 97.1 The Ticket | ‘Get a Mammogram’

Listen Now